Teladoc Health, Inc.
Financials
Valuation Metrics
Teladoc Health, Inc.'s Market Cap is $1.56B. At end of 2025 it was $1.23B. Ranked #2158 of 3,116 in US market (top 69%), #1314 of 1,644 on NYSE (top 80%), #137 of 203 in Health Care Equipment & Services (top 67%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.56B | US#2,158/3,116 Sec#137/203 |
| Revenue | $2.47B | US#1,299/3,116 Sec#82/203 |
| Net Income | $-155M | US—/3,116 Sec—/203 |
| Total Assets | $2.78B | US#1,869/3,116 Sec#91/203 |
| Net Assets | $1.29B | US#1,573/3,116 Sec#85/203 |
| Employees | 5,124 | US#1,215/3,116 Sec#88/203 |
| Value | ||
| P/B | 1.20x | US#597/3,116 Sec#23/203 |
| P/S | 0.63x | US#426/3,116 Sec#34/203 |
| EV/EBITDA | 7.35x | US—/3,116 Sec—/203 |
| FCF Yield | 14.93% | US#298/3,116 Sec#8/203 |
| Profitability | ||
| ROE | -11.96% | US#2,409/3,116 Sec#141/203 |
| ROA | -5.58% | US#2,573/3,116 Sec#145/203 |
| Op. Margin | -6.07% | US#2,481/3,116 Sec#150/203 |
| Revenue Growth | -2.38% | US#2,323/3,116 Sec#174/203 |
| Financial Health | ||
| Debt Ratio | 114.34% | US#1,190/3,116 Sec#112/203 |
| Total Debt | $1.03B | US#1,504/3,116 Sec#81/203 |
| FCF | $233M | US#1,323/3,116 Sec#77/203 |
| Cash | $850M | US#812/3,116 Sec#42/203 |
| Current Ratio | 0.87x | US#2,466/3,116 Sec#199/203 |
| Net Debt/EBITDA | 0.74x | US—/3,116 Sec—/203 |
| Performance | ||
| 1Y Return | 0.06% | US#1,638/3,116 Sec#120/203 |
| 1M Return | 56.43% | US#20/3,116 Sec#6/203 |
| From 52W High | -12.69% | US#1,002/3,116 Sec#90/203 |
| 1Y MDD | -44.54% | US#2,326/3,116 Sec#152/203 |
| Trading | ||
| Volume | 5,122,870 shares | US#77/3,116 Sec#2/203 |
| Trading Value | $44M | US#647/3,116 Sec#53/203 |
| Per Share | ||
| EPS | $-0.86 | US—/3,116 Sec—/203 |
| BPS | $7.17 | US#2,058/3,116 Sec#122/203 |
Company Info
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.